| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/08/2000 | US6022852 Comprising cyclosporin a, tocopherol, polyethylene glycol 1000 succinate and, optionally, an emulsifier, with the exception of vegetable oil or fat; administering by mouth; kidney disorders; topical; psoriasis, wound healing agents |
| 02/08/2000 | US6022564 Method for producing a microparticle |
| 02/08/2000 | US6022563 Phenylbutazone carrier formulation |
| 02/08/2000 | US6022562 Medicinal and/or nutritional microcapsules for oral administration |
| 02/08/2000 | US6022561 Galactolipid material extracted from cereals selected from the group consisting of wheat, rye, and oats, containing at least about 50% by weight of digalactosyldiacylglycerol; drug delivery, cosmetics |
| 02/08/2000 | US6022560 For treating, controlling or preventing viral and fungal infections and inflammation and antagonizing the activities of paf (platelet-activating factor); also effective in blocking ultraviolet radiation |
| 02/08/2000 | US6022559 Aqueous dispersion of dehydration-resistant vesicles |
| 02/08/2000 | US6022554 Polymeric microporous film coated subcutaneous implant |
| 02/08/2000 | US6022545 Usage of pathogen-killing foams |
| 02/08/2000 | US6022533 Tablets containing anion exchange resin |
| 02/08/2000 | US6022528 Effervescent oral care with improved interproximal delivery properties and taste, comprising an alkali metal bicarbonate and second composition with specific amount of acidic compound to generate carbon dioxide without acidic salica |
| 02/08/2000 | US6022527 Method of treating lung diseases with uridine 5'-diphosphate and analogs thereof |
| 02/08/2000 | US6022525 Preparation of diagnostic agents |
| 02/08/2000 | US6022501 pH-sensitive microcapsules |
| 02/08/2000 | US6022500 Polymer encapsulation and polymer microsphere composites |
| 02/08/2000 | US6022499 Method for striping or marbleizing capsules |
| 02/08/2000 | CA2271571C Improved phase separation-microencapsulated pharmaceutical compositions useful for alleviating dental disease |
| 02/08/2000 | CA2241342C Pharmaceutical tablets comprising an nsaid and a prostaglandin |
| 02/08/2000 | CA2234364C Compositions for inhibiting platelet aggregation |
| 02/08/2000 | CA2163246C Non-hazardous pest control |
| 02/08/2000 | CA2004597C Topical formulations and transdermal delivery systems containing 1-isobutyl-1h-imidazo-[4,5-c]quinoline-4-amine |
| 02/08/2000 | CA2004064C Supported drugs with increased dissolution rate, and a process for theirpreparation |
| 02/03/2000 | WO2000005359A1 Use of prohibitin rna in treatment of cancer |
| 02/03/2000 | WO2000005307A1 Coating and excipient agent for oral or dermal dosage forms |
| 02/03/2000 | WO2000005274A1 Method for producing powder-shaped cross-linked polymerizates |
| 02/03/2000 | WO2000005270A1 Biocompatible polymers, preparation method and compositions containing same |
| 02/03/2000 | WO2000005269A1 Polymer complexes of glucuronoglucanes |
| 02/03/2000 | WO2000005257A1 Pectic substance as a growth factor stabilizer |
| 02/03/2000 | WO2000004954A2 Novel urokinase inhibitors |
| 02/03/2000 | WO2000004939A1 Dental pin |
| 02/03/2000 | WO2000004937A1 Flat flexible materials |
| 02/03/2000 | WO2000004925A1 Slow release formulations comprising anionic polysaccharide |
| 02/03/2000 | WO2000004924A1 Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 02/03/2000 | WO2000004920A2 Method of vaccination of newly hatched poultry |
| 02/03/2000 | WO2000004916A1 Encapsulation of water soluble peptides |
| 02/03/2000 | WO2000004907A1 An antilipemic formulation |
| 02/03/2000 | WO2000004902A1 Stabilized carvedilol injection solution |
| 02/03/2000 | WO2000004899A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | WO2000004897A1 Bioimplant formulation |
| 02/03/2000 | WO2000004896A1 Solid preparation containing sparingly soluble nsaids |
| 02/03/2000 | WO2000004894A2 Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate |
| 02/03/2000 | WO2000004891A2 Anti-ulcer composition |
| 02/03/2000 | WO2000004886A1 Formulations for the transdermal administration of fenoldopam |
| 02/03/2000 | WO2000004884A1 Pharmaceutical preparations for the topical treatment of mucocutaneous herpes infections and herpetic keratitis of the eye |
| 02/03/2000 | WO2000004883A1 Diltiazem controlled release formulation and method of manufacture |
| 02/03/2000 | WO2000004882A1 Formulations of anionic polysaccharides |
| 02/03/2000 | WO2000004881A1 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
| 02/03/2000 | WO2000004880A1 A wet granulation method for preparing a stable pharmaceutical formulation |
| 02/03/2000 | WO2000004879A1 Granule modulating hydrogel system |
| 02/03/2000 | WO2000004878A1 Pharmaceutical composition in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy |
| 02/03/2000 | WO2000004877A1 Suppository formulations comprising anionic polysaccharide |
| 02/03/2000 | WO2000004876A2 Controlled release of bioactive substances |
| 02/03/2000 | WO2000004875A2 Preparation of aqueous clear solution dosage forms with bile acids |
| 02/03/2000 | WO2000004874A2 Soft gelatine capsules containing olive oil |
| 02/03/2000 | WO2000004862A2 Bioenhanced formulations comprising eprosartan in oral solid dosage form |
| 02/03/2000 | WO1999066903A3 Large porous particles emitted from an inhaler |
| 02/03/2000 | WO1999060120A3 Soluble t cell receptor |
| 02/03/2000 | WO1999060119A3 Multivalent t cell receptor complexes |
| 02/03/2000 | WO1999058504A9 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament |
| 02/03/2000 | DE19834876A1 Verfahren zur Herstellung sphärischer Teilchen bei der Kristallisation A process for the preparation of spherical particles in the crystallization |
| 02/03/2000 | DE19834820A1 Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl Emulsifier-free finely dispersed systems of the oil-in-water and water-in-oil |
| 02/03/2000 | DE19834819A1 Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl Emulsifier-free finely dispersed systems of the oil-in-water and water-in-oil |
| 02/03/2000 | DE19834507A1 Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil Pharmaceutical, water-soluble tablet formulation for use of sildenafil |
| 02/03/2000 | DE19834506A1 Transmucosales therapeutisches System zur Anwendung von Sildenafil Transmucosal therapeutic system for the administration of sildenafil |
| 02/03/2000 | DE19834505A1 Transdermal therapeutic system useful for treating male sexual impotence contains sildenafil |
| 02/03/2000 | DE19834496A1 Verbesserte Freisetzung von Ibuprofen aus Heißschmelzklebemassen durch Zusatz von pharmazeutischen Hilfsstoffen Enhanced release of ibuprofen from hot melt adhesive compositions by the addition of pharmaceutical excipients |
| 02/03/2000 | DE19834025A1 Mikrokapseln hergestellt aus Cycloolefinpolymeren oder Cycloolefincopolymeren und deren Verwendung zur kontrollierten Wirkstoffabgabe Microcapsules made of cyclic olefin polymers or cycloolefin and their use in controlled drug delivery |
| 02/03/2000 | DE19824016C1 Implantierbare Vorrichtung zur Applikation einer Wirklösung An implantable device for application of an active solution |
| 02/03/2000 | CA2338345A1 Encapsulation of water soluble peptides |
| 02/03/2000 | CA2338307A1 Pectic substance as a growth factor stabilizer |
| 02/03/2000 | CA2337349A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | CA2336595A1 Use of prohibitin rna in treatment of cancer |
| 02/03/2000 | CA2335620A1 Solid preparation containing sparingly soluble nsaids |
| 02/02/2000 | EP0976776A1 Hypertonic aqueous dispersions of unfractioned collagen, a method and a device for the preparation of said dispersions |
| 02/02/2000 | EP0976767A1 Methacrylic polymer having terminal functional group and composition thereof |
| 02/02/2000 | EP0976412A1 Device for wound treatment and method of producing the same |
| 02/02/2000 | EP0976408A1 Cation exchange resin preparation containing gelling agent |
| 02/02/2000 | EP0976407A1 Antiseptic composition |
| 02/02/2000 | EP0976406A1 Transdermal composition containing glibenclamide and benzyl alcohol |
| 02/02/2000 | EP0976405A1 Base composition for percutaneous absorption and percutaneously absorbable preparation containing the base composition |
| 02/02/2000 | EP0976400A1 Preventive or remedy for kidney diseases |
| 02/02/2000 | EP0976399A1 Propolis extract |
| 02/02/2000 | EP0976397A2 Improved release of ibuprofen from pressure-sensitive hot melt adhesives by the addition of pharmaceutical excipients |
| 02/02/2000 | EP0976396A1 Cosmetic or pharmaceutical patch and packaging |
| 02/02/2000 | EP0976395A1 Tablet for extended release of a drug in the stomach |
| 02/02/2000 | EP0976394A1 New injectable formulations |
| 02/02/2000 | EP0976382A1 Cosmetic or dermopharmaceutical patch |
| 02/02/2000 | EP0976381A1 Dermatologic preparation |
| 02/02/2000 | EP0976328A2 Ectoparasite controlling agent for animals |
| 02/02/2000 | EP0975780A2 Il-2 gene expression and delivery systems and uses |
| 02/02/2000 | EP0975739A1 Stimulation, culture and preservation of pancreatic and other cells |
| 02/02/2000 | EP0975691A1 Multifunctional polymeric tissue coatings |
| 02/02/2000 | EP0975680A1 Interactive system for substance presentation and elimination |
| 02/02/2000 | EP0975609A1 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent |
| 02/02/2000 | EP0975532A1 Multi-compartment rehydrating container |
| 02/02/2000 | EP0975367A1 Improved delivery of drugs to mucosal surfaces |
| 02/02/2000 | EP0975357A1 Transdermal delivery system |
| 02/02/2000 | EP0975351A1 Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| 02/02/2000 | EP0975350A1 Use of an extract of alchemilli vulgaris |
| 02/02/2000 | EP0975348A1 Stabilized tibolone compositions |